Ocugen OCGN
NASDAQ OCGN
$1.02 +0.02 (+2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ocugen (OCGN) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Ocugen (OCGN) posted Return on Capital Employed [ROCE] of -224.57% for Q1 2026, down 123.73 percentage points from -100.84% a year earlier but up 4.11 percentage points from the prior quarter.

Analysis

Ocugen (OCGN) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Ocugen's Return on Capital Employed [ROCE] came in at -157.54%, down 52.05 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -42.35 percentage points (FY2020 to FY2025).
  • In prior years, Ocugen's Return on Capital Employed [ROCE] was -105.49% in FY2024 (-11.20 pp), -94.29% in FY2023 (+18.94 pp), -113.23% in FY2022 (-15.81 pp) and -97.41% in FY2021 (+17.78 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -228.68% in Q4 2025 to a high of -41.44% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of -29.32 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2021, with a gain of 79.31 percentage points; the weakest was Q1 2026, with a drop of 123.73 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -228.68% (Q4 2025), -169.61% (Q3 2025) and -134.97% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Ocugen 345.83 Mn 162.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -224.57%
Dec 31, 2025 -228.68%
Sep 30, 2025 -169.61%
Jun 30, 2025 -134.97%
Mar 31, 2025 -100.84%
Dec 31, 2024 -108.21%
Sep 30, 2024 -147.82%
Jun 30, 2024 -183.08%
Mar 31, 2024 -141.76%
Dec 31, 2023 -124.75%
Sep 30, 2023 -124.57%
Jun 30, 2023 -132.14%
Mar 31, 2023 -116.07%
Dec 31, 2022 -106.16%
Sep 30, 2022 -81.39%
Jun 30, 2022 -55.93%
Mar 31, 2022 -63.38%
Dec 31, 2021 -55.78%
Sep 30, 2021 -41.44%
Jun 30, 2021 -55.41%
API Access

Ocugen Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OCGN&period=max&api_key=YOUR_API_KEY